Latin America Dupuytren’s Disease Market Size & Outlook
The dupuytren’s disease market in Latin America is expected to reach a projected revenue of US$ 93.4 million by 2030. A compound annual growth rate of 5.4% is expected of Latin America dupuytren’s disease market from 2023 to 2030.
Revenue, 2022 (US$M)
$61.5
Forecast, 2030 (US$M)
$93.4
CAGR, 2023 - 2030
5.4%
Report Coverage
Latin America
Latin America dupuytren’s disease market, 2018-2030 (US$M)
Related Markets
Latin America dupuytren’s disease market highlights
- The Latin America dupuytren’s disease market generated a revenue of USD 61.5 million in 2022.
- The market is expected to grow at a CAGR of 5.4% from 2023 to 2030.
- In terms of segment, type ii was the largest revenue generating disease type in 2022.
- Type II is the most lucrative disease type segment registering the fastest growth during the forecast period.
- Country-wise, Mexico is expected to register the highest CAGR from 2023 to 2030.
Latin America data book summary
| Market revenue in 2022 | USD 61.5 million |
| Market revenue in 2030 | USD 93.4 million |
| Growth rate | 5.4% (CAGR from 2022 to 2030) |
| Largest segment | Type ii |
| Fastest growing segment | Type II |
| Historical data covered | 2018 - 2021 |
| Base year for estimation | 2022 |
| Forecast period covered | 2023 - 2030 |
| Quantitative units | Revenue in USD million |
| Market segmentation | Type I, Type II, Type III |
| Key market players worldwide | Bayer AG, Novartis AG ADR, Pfizer Inc, Bristol-Myers Squibb Co, GSK PLC, AstraZeneca PLC, Hikma Pharmaceuticals PLC, LEO Pharma, Fresenius SE & Co KGaA, Nantong Jinghua Pharmaceutical, Actiza Pharmaceutical Pvt. Ltd, Eppendorf, Endo Pharmaceuticals, Spear Pharmaceuticals |
Other key industry trends
- In terms of revenue, Latin America region accounted for 1.5% of the global dupuytren’s disease market in 2022.
- Globally, Asia Pacific is projected to lead the regional market in terms of revenue in 2030.
- Asia Pacific is the fastest growing regional market and is projected to reach USD 2,533.8 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Dupuytren’s Disease Market Scope
Dupuytren’s disease market segmentation & scope
Dupuytren’s Disease Market Companies
| Name | Profile | # Employees | HQ | Website |
|---|
Latin America dupuytren’s disease market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to dupuytren’s disease market will help companies and investors design strategic landscapes.
Type ii was the largest segment with a revenue share of 62.6% in 2022. Horizon Databook has segmented the Latin America dupuytren’s disease market based on type i, type ii, type iii covering the revenue growth of each sub-segment from 2018 to 2030.
- Latin America Dupuytren’s Disease Disease Type Outlook (Revenue, USD Million, 2018-2030)
- Type I
- Type II
- Type III
- Latin America Dupuytren’s Disease Type Outlook (Revenue, USD Million, 2018-2030)
- Diagnosis
- Treatment
- Latin America Dupuytren’s Disease End Use Outlook (Revenue, USD Million, 2018-2030)
- Hospitals
- Clinics
- Academic & Research
- Other End Users
Reasons to subscribe to Latin America dupuytren’s disease market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Latin America dupuytren’s disease market databook
-
Our clientele includes a mix of dupuytren’s disease market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of continent-level data and insights on the Latin America dupuytren’s disease market, including forecasts for subscribers. This continent databook contains high-level insights into Latin America dupuytren’s disease market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Latin America dupuytrens disease market report size, by country, 2018-2030 (US$M)
Latin America Dupuytren’s Disease Market Share, 2022 & 2030 (US$M)
Related industry reports
Related regional statistics
No records
No related regions found.
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
